Picture of Psybio Therapeutics logo

PSYB.H Psybio Therapeutics Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Psybio Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
2020
June 30th
2021
December 31st
2022
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
fx
Final
FinalFinal
Cash
Short Term Investments
Cash and Short Term Investments0.2060.1930.1623.810.001
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.2060.1930.16240.253
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.127
Other Long Term Assets
Total Assets0.2060.1930.1624.010.39
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.0360.0430.0341.041.98
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.0360.0430.0341.291.98
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.170.150.1282.72-1.59
Total Liabilities & Shareholders' Equity0.2060.1930.1624.010.39
Total Common Shares Outstanding